ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 179 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $96 | -92.3% | 30,282 | -88.0% | 0.00% | -100.0% |
| Q2 2023 | $1,252 | -40.9% | 251,900 | -41.2% | 0.00% | -33.3% |
| Q1 2023 | $2,118 | -23.5% | 428,700 | -2.6% | 0.00% | -25.0% |
| Q4 2022 | $2,768 | -100.0% | 440,100 | -54.8% | 0.00% | -60.0% |
| Q1 2022 | $8,880,000 | -51.7% | 974,700 | +38.4% | 0.01% | -56.5% |
| Q2 2021 | $18,371,000 | +480.6% | 704,400 | +739.6% | 0.02% | +666.7% |
| Q3 2020 | $3,164,000 | +193.2% | 83,900 | +232.9% | 0.00% | +200.0% |
| Q2 2020 | $1,079,000 | – | 25,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $45,386,000 | 9.32% |
| TPG Group Holdings (SBS) Advisors, Inc. | 18,716,306 | $472,400,000 | 5.23% |
| Wildcat Capital Management, LLC | 1,515,524 | $38,252,000 | 4.81% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 900,143 | $22,720,000 | 3.28% |
| Coastal Bridge Advisors, LLC | 385,824 | $9,738,000 | 1.93% |
| Casdin Capital, LLC | 945,000 | $23,852,000 | 0.71% |
| DSAM Partners (London) Ltd | 208,798 | $5,270,000 | 0.62% |
| BAINCO INTERNATIONAL INVESTORS | 152,839 | $3,858,000 | 0.44% |
| Pier Capital, LLC | 152,071 | $3,838,000 | 0.41% |
| Woodline Partners LP | 567,539 | $14,325,000 | 0.38% |